Dr Alexander Barrow
Senior Lecturer, Immunology
Department of Microbiology and Immunology
43 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
The NKp44-1 Isoform Is an Activating Receptor for PDGF-DD Expressed on Natural Killer Cells.
DOI: 10.3390/cancers180710992025
Journal article
Pomalidomide enhances CD8 T and NK cell mediated killing of HIV-infected cells
DOI: 10.1016/j.ebiom.2025.1060042025
Journal article
Reduced HLA-I Transcript Levels and Increased Abundance of a CD56dim NK Cell Signature Are Associated with Improved Survival in Lower-Grade Gliomas
DOI: 10.3390/cancers170915702025
Thesis / Dissertation
The molecular and cellular basis of NK cell recognition of Platelet-derived growth factor-D
2025
Journal article
Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer
DOI: 10.3389/fimmu.2024.14746522025
Journal article
Brain-Resident MAIT Cells Infiltrate GL261 Tumors, and Activated MAIT Cell Signatures Are Associated With Improved Outcomes in Glioma
DOI: 10.1212/NXI.00000000002005462021
Research Grant
A Personalised Therapeutic Approach for HBV Associated Liver Cancer
RECENT SCHOLARLY WORKS
2024
Journal article
Cutting Edge: PDGF-DD Binding to NKp44 Costimulates TLR9 Signaling and Proinflammatory Cytokine Secretion in Human Plasmacytoid Dendritic Cells
DOI: 10.4049/jimmunol.22004962024
Journal article
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model
DOI: 10.1126/scitranslmed.adj90522023
Journal article
cellsig plug-in enhances CIBERSORTx signature selection for multidataset transcriptomes with sparse multilevel modelling
DOI: 10.1093/bioinformatics/btad6852023
Journal article
IL17RB and IL17REL Expression Are Associated with Improved Prognosis in HPV-Infected Head and Neck Squamous Cell Carcinomas
DOI: 10.3390/pathogens120405722021
Journal article
Editorial: Innate Lymphoid Cells in Cancer: Friends or Foes?
DOI: 10.3389/fimmu.2021.804156
RECENT PROJECTS
2020
Research Grant
A Personalised Therapeutic Approach for HBV Associated Liver Cancer